Nesslage Roman, Radtke Kerstin, Hohloch Lisa, Floerkemeier Thilo, Windhagen Henning, Lewinski Gabriela von
Orthopädische Klinik im Diakovere Annastift, Medizinische Hochschule Hannover.
Klinik für Orthopädie und Unfallchirurgie, Universitätsklinikum Freiburg.
Z Orthop Unfall. 2017 Apr;155(2):194-200. doi: 10.1055/s-0042-118602. Epub 2017 Jan 10.
Total hip arthroplasty (THA) is very frequently performed. Despite low complication rates, revisions play an important clinical and economical role. The aim of this study was to identify comorbid diseases of patients undergoing primary THA and their potential influence on the survival of hip replacements. A total of 867 patients were included in this retrospective study. All revisions were reviewed that took place at our hospital within one year of primary implantation of THA. Comorbid diseases were detected by administrative data, using the Elixhauser definition, which includes thirty diseases. The Cox regression model and Fisher's exact test were used to examine correlations between comorbidities and risk of revision. 41 Patients required re-operation within the first year of surgery. The presence of one or more of the analysed comorbidities was associated with a greater risk of revision. Deficiency anemia, obesity, drug abuse, alcohol abuse, fluid and electrolyte disorders and peripheral vascular disorders were associated with increased risk of revision (p < 0.05 for all comparisons).
The total number of comorbidities and specific comorbid diseases was independently associated with an increased risk of re-operation within the first year of total hip arthroplasty. This information could be helpful in pre- and post-operative risk adjustment and patient selection.
